FAZA PET as Biomarker for Hypoxia in Rectal Cancer (Q63578444)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FAZA PET as Biomarker for Hypoxia in Rectal Cancer |
clinical trial |
Statements
18F-Fluoroazomycin Arabinoside (FAZA) Positron Emission Tomography/Magnetic Imaging Resonance (PET/MRI) as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study (English)
0 references
May 2016
0 references
June 2019
0 references
10
0 references
18 year
0 references